Intra-arterial infusion of 5-fluorouracil, leucovorin, epirubicin and carboplatin (FLEC regimen) in unresectable pancreatic cancer: Results of a ten-year experience

In Vivo

Volumn 20, Issue 6 A, 2006, Pages 751-756

  Mambrini, Andrea ^a   Sanguinetti, Franco ^a   Pacetti, Paola ^a   Caudana, Roberto ^b   Iacono, Calogero ^c   Guglielmi, Alfredo ^c   Guadagni, Stefano ^d   Del Freo, Alfonso ^a   Fiorentini, Giammaria ^e   Cantore, Maurizio ^a  

^a Carrara City Hospital   (Italy)

^b CARLO POMA HOSPITAL   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d UNIVERSITY OF L'AQUILA   (Italy)

^e SAN GIUSEPPE HOSPITAL   (Italy)

Author keywords

Intra arterial chemotherapy; Pancreatic cancer

Indexed keywords

CARBOPLATIN; EPIRUBICIN; FAMOTIDINE; FLUOROURACIL; FOLINIC ACID; GRANISETRON; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ANGINA PECTORIS; ANGIOGRAPHY; ARTERY DISSECTION; ARTERY INTIMA; ARTICLE; BLOOD TOXICITY; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CELIAC ARTERY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HEMATEMESIS; HUMAN; ILIAC ARTERY; INOPERABLE CANCER; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PANCREAS CARCINOMA; SIDE EFFECT; SUDDEN DEATH; SURVIVAL TIME; THROMBOCYTOPENIA; TRANSIENT ISCHEMIC ATTACK;

EID: 33846062506     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ and Thun MJ: Cancer statistics. CA Cancer J Clin 55: 10-30, 2005.
2. Hafin SA and Schmiegel WH: Recent discoveries in cancer genetics of exocrine pancreatic neoplasia. Digestion 59: 493-501, 1998.
3. Burris HA, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD and Von Hoff DD: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15(6): 2403-2413, 1997.
4. Reni M, Cordio S, Milandri C, Passoni P, Bonetto E, Oliani C, Luppi G, Nicoletti R, Galli L, Bordonaro R, Passardi A, Zerbi A, Balzano G, Aldrighetti L, Staudacher C, Villa E and Di Carlo V: Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial, lancet Oncol 6: 369-376, 2005.
5. Moore MJ, Goldstein D, Hamm J, Figer A, Hecht J, Gallinger S, Au H, Ding K, Christy-Bittel J and Parulekar W: Erlotinib plus gemcitabine compared to gemcitabine alone in patients with advanced pancreatic cancer. A phase III trial of the National Cancer Institute od Canada Clinical Trials Group (NCIC-CTG). Proc Am Soc Clin Oncol 23: 1s. Abs1, 2005.
6. Bengmark S and Andren-Sandberg A: Infusion chemotherapy in inoperable pancreatic carcinoma. Recent Results Cancer Res 86: 13-14, 1983.
7. Aigner KR and Gailhofer S: Celiac axis infusion and microembolization for advanced stage III/IV pancreatic cancer - a phase II stady on 265 cases. Anticancer Res 25: 4407-4412, 2005.
8. Gansauge F, Link KH, Rilinger N, Kunz R and Beger HG: Regional chemotherapy in advanced pancreatic carcinoma. Med Klin 90: 501-515, 1995.
9. Muchmore JH: Treatment of advanced pancreatic cancer with regional chemotherapy plus hemofilatration. Semin Surg Oncol 11: 1-14, 1995.
10. Fiorentini G, Poddie D and Ricci S: Intra-aortic stop-flow infusion with hypoxic abdominal perfusion in UICC stage III/IV pancreatic carcinoma: report of a phase II study. Reg Cancer Treat 9: 88-91, 1996.
11. Cantore M, Pederzoli P, Cornalba G, Fiorentini G, Guadagni S, Miserocchi L, Frassoldati A, Ceravolo C, Smerieri F and Muchmore JH: Intra-arterial chemotherapy for unresectable pancreatic cancer. Ann Oncol 11: 569-573, 2000.
12. Cantore M, Serio G, Pederzoli P, Mambrini A, Iacono C, Pulica C, Capelli P, Lombardi M, Torri T, Pacetti P, Pagani M and Fiorentini G: Adjuvant intra-arterial 5-fluorouracil, leucovorin epirubicin and carboplatin with or without systemic gemcitabine after curative resection for pancreatic adenocarcinoma. Cancer Chemother Pharmacol 58: 504-508, 2006.
13. Miller AB, Hoogstraten B, Staquet M and Winkler A: Reporting results of cancer treatment. Cancer 47: 2507-2514, 1981.
14. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N and Perucho M: Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53: 549-554, 1988.
15. Goldstein LJ, Galski H, Fojo A, WiUingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W and Brodeur GM: Expression of the multidrug resistance gene product P-glycoprotein in human cancer. J Natl Cancer Inst 81: 116, 1989.
16. Ishida H, Makino T, Kobayashi M and Tsuneoka K: Laparoscopic measurement of pancreatic blood flow. Endoscopy 15: 107-110, 1983.
17. Collins JM: Pharmacologic rationale for regional drug delivery. J Clin Oncol 2: 498-504, 1984.
18. Donatini B and Rougier P: Anatomical basis for pancreatic locoregional chemotherapy. Reg Cancer Treat 4: 272-276, 1992.
19. Weiss L, Harlos JP, Hartveit F, Maartmann-Moe H, Svendsen E, Christen S, Torhorst J, Horne CHV and Johnson SJ: Metastatic pattern from cancers of the pancreas: an analysis of 558 autopsies. Reg Cancer Treat 4: 265-271, 1992.
20. Cantore M, Fiorentini G, Aitini E, Davitti B, Cavazzini G, Rabbi C, Lusenti A, Bertani M, Morandi C and Benedini V: Intra-arterial hepatic carboplatin based chemotherapy for ocular melanoma metastatic to the liver. Report of a phase II study. Tumori 80: 37-39, 1994.
21. Masuyama M, Taniguchi H, Takeuchi K, Miyata K, Koyama H, Tanaka H, Higashida T, Koishi Y, Mugitani T and Yamaguchi T: Recurrence and survival rate of advanced gastric cancer after preoperative intra-arterial infusion therapy. Gan to Kagaku Ryoho 21: 2253-2255, 1994.
22. Tanaka H, Taniguchi H, Koyama H, Miyata K, Suganuma Y, Takeuchi K, Oguro A, Takahashi T and Torii T: A case of complete response by intermittent intra-arterial injection of 5-fluorouracil and carboplatin for liver metastases due to pancreatic cancer. Gan to Kagaku Ryoho 20: 1669-1671, 1993.
23. Anderson JS, Burris HA and Casper E: Development of a new system for assessing clinical benefit for patients with advanced pancreatic cancer. Proc Am Soc Clin Oncol 13:461 (abstr 1600), 1994.
24. Ohigashi H, Ishikawa O, Nakamori S, Sasaki Y, Masutani S, Kameyama M, Hiratsuka M, Kabuto T, Furukawa H and Imaoka S: Evaluation of intra-arterial infusion chemotherapy and radical pancreateetomy in patients with locally advanced pancreatic cancer. Gan to Kagaku Ryoho 20: 1672-1675, 1993.
25. Link KH, Gansauge F, Pillasch J and Beger HG: Multimodality therapies in ductal pancreatic cancer. The future. Int J Pancreatology 21: 71-83, 1997.